RECRO PHARMA INC has a total of 57 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, medical technology and machines are OPIANT PHARMACEUTICALS INC, OPTERION HEALTH AG and VALEANT PHARMACEUTICALS NORTH AMERICA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | China | 4 | |
#4 | New Zealand | 4 | |
#5 | Canada | 3 | |
#6 | Mexico | 3 | |
#7 | Singapore | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Australia | 2 | |
#10 | Chile | 2 | |
#11 | Colombia | 2 | |
#12 | Costa Rica | 2 | |
#13 | Dominican Republic | 2 | |
#14 | Ecuador | 2 | |
#15 | Israel | 2 | |
#16 | Japan | 2 | |
#17 | Peru | 2 | |
#18 | Brazil | 1 | |
#19 | Hong Kong | 1 | |
#20 | Honduras | 1 | |
#21 | Hungary | 1 | |
#22 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Syringes | |
#4 | Unspecified technologies | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sharr Christopher T | 26 |
#2 | Mack Randall J | 25 |
#3 | Henwood Geraldine A | 23 |
#4 | Koleng Jr John Joseph | 17 |
#5 | Freyer Charles Alexander | 16 |
#6 | Mack Randall Jerome | 15 |
#7 | Henwood Geraldine Anne | 14 |
#8 | Sharr Christopher Thomas | 12 |
#9 | Koleng John Joseph Jr | 7 |
#10 | Ryde Tuula | 6 |
Publication | Filing date | Title |
---|---|---|
CA2858721A1 | Intranasal dexmedetomidine compositions and methods of use thereof | |
NZ601195A | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
EP3305281A1 | Sublingual dexmedetomidine compositions and methods of use thereof |